Chemotherapy News and Research

Latest Chemotherapy News and Research

Mayo Clinic researchers identify new possible treatment choice for triple negative breast cancer

In a recent study published in the Journal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndrome may be useful to treat triple-negative breast cancer, which is one of the most aggressive and lethal types of breast cancer.

16 May 2018

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

16 May 2018

Study: Gadolinium deposition in brain not associated with dosage

Investigators at Children's Hospital Los Angeles have determined that in children receiving gadolinium as a contrast agent to enhance MRI examinations, signal changes attributed solely to deposition of this material in the brain are not dependent on the amount of gadolinium administered but rather these changes are seen in association with other factors such as the presence of brain tumors and treatment using brain irradiation. Results of the study were just published in the journal, Radiology.

15 May 2018

Genetic fixer-uppers could aid in predicting prognosis of patients with bladder cancer

Mutations in genes that help repair damage to DNA may aid in predicting the prognosis of patients with bladder and other related cancers, according to researchers.

15 May 2018

Researchers test new cancer research model that may reduce cost and speed up studies

A new model for improving how clinical trials are developed and conducted by bringing together academic cancer experts and pharmaceutical companies is being tested by research experts at The University of Texas MD Anderson Cancer Center.

15 May 2018

UTA bioengineering professor successfully patents new cancer trap

The University of Texas at Arlington has successfully patented in Europe an implantable medical device that attracts and kills circulating cancer cells that was invented by a faculty member. This cancer trap can be used for early diagnosis and treatment of metastasized cancer.

14 May 2018

European regulatory approves BMG Pharma’s GelX for prevention of oral mucositis

BMG Pharma S.r.l., an innovative specialty pharmaceutical company, is pleased to announce the European regulatory approval for its GelX product to be used for the prevention of oral mucositis.

14 May 2018

Adding chemotherapy to treatment regimen can give children with PVS a chance to grow up

Pulmonary vein stenosis (PVS) is a rare disease in which abnormal cells build up inside the veins responsible for carrying oxygen-rich blood from the lungs to the heart. It restricts blood flow through these vessels, eventually sealing them off entirely if left untreated.

11 May 2018

Trump vows (again) to lower drug prices but skeptics doubt much will change

President Donald Trump, armed with the expertise of staff seasoned in the ways of the drug industry, unveiled his blueprint to address sky-high drug prices Friday afternoon, promising that increasing industry competition will help Americans save at the pharmacy counter.

11 May 2018

Oral drug reduces venous thromboembolism recurrence among cancer patients

Research from the University of Warwick indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition.

11 May 2018

New survey shows 80% of oncologists have discussed medical marijuana use with patients

Data from a new survey show that as many as 80% of oncologists have discussed medical marijuana use with their patients.

11 May 2018

Living apart together: A new option for older adults

Three years ago, William Mamel climbed a ladder in Margaret Sheroff's apartment and fixed a malfunctioning ceiling fan. "I love that you did this," Sheroff exclaimed as he clambered back down.

11 May 2018

Early intervention highly effective in reversing lymphedema

A study conducted by researchers at The University of Kansas Cancer Center has found that early, ongoing screening of lymphatic function and immediate patient-administered therapies are highly effective in improving outcomes for women at high risk for breast cancer related lymphedema.

10 May 2018

Researchers discuss challenges and barriers faced in the development of personalized medicine

Personalized medicine has the potential to improve the treatment and care of patients. This promising approach has already borne fruit, with a handful of targeted therapies for cancer now in use.

10 May 2018

New case study shows CAR T therapy as viable option for AML patients

Chimeric Antigen Receptor T-cell therapy, also known as CAR T therapy, was named the biggest research breakthrough of 2017 by the American Society of Clinical Oncology. The personal gene therapy utilizes a patient's own immune cells to fight cancer.

9 May 2018

Research findings could lead to new therapies to curb ovarian cancer metastasis

In order to spread their destruction, ovarian cancer cells must break free from their tumor home, travel through the fluid in the peritoneal cavity and attach to the outside of the abdominal organs--surfaces that are, by necessity, not sticky.

9 May 2018

Prostate cancer campaigner uses Paxman Scalp Cooler to retain hair during treatment

A Cardiff man, who founded The Red Sock Campaign to help raise awareness of prostate cancer, is using a pioneering treatment to help keep his hair during chemotherapy.

From Paxman 9 May 2018

Flushing the bladder with common chemotherapy drug after surgery can reduce bladder cancer recurrence

Flushing the bladder with a common chemotherapy drug immediately after surgery significantly reduces the chances of bladder cancer returning, according to a major study by SWOG, an international clinical trials network funded by the National Cancer Institute.

9 May 2018

Neon Therapeutics evaluates safety, efficacy of NEO-PV-01 in combination with KEYTRUDA and chemotherapy

Neon Therapeutics, a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that it has treated the first patient in a clinical trial evaluating its proprietary personal neoantigen vaccine, NEO-PV-01, in combination with Merck's anti-PD-1 therapy, KEYTRUDA®, along with chemotherapy.

8 May 2018

How the farm bill could erode part of the ACA

Some Republican lawmakers continue to try to work around the federal health law's requirements. That strategy can crop up in surprising places. Like the farm bill.

8 May 2018

Chemotherapy News and Research

Latest Chemotherapy News and Research

Mayo Clinic researchers identify new possible treatment choice for triple negative breast cancer

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

Study: Gadolinium deposition in brain not associated with dosage

Genetic fixer-uppers could aid in predicting prognosis of patients with bladder cancer

Researchers test new cancer research model that may reduce cost and speed up studies

UTA bioengineering professor successfully patents new cancer trap

European regulatory approves BMG Pharma’s GelX for prevention of oral mucositis

Adding chemotherapy to treatment regimen can give children with PVS a chance to grow up

Trump vows (again) to lower drug prices but skeptics doubt much will change

Oral drug reduces venous thromboembolism recurrence among cancer patients

New survey shows 80% of oncologists have discussed medical marijuana use with patients

Living apart together: A new option for older adults

Early intervention highly effective in reversing lymphedema

Researchers discuss challenges and barriers faced in the development of personalized medicine

New case study shows CAR T therapy as viable option for AML patients

Research findings could lead to new therapies to curb ovarian cancer metastasis

Prostate cancer campaigner uses Paxman Scalp Cooler to retain hair during treatment

Flushing the bladder with common chemotherapy drug after surgery can reduce bladder cancer recurrence

Neon Therapeutics evaluates safety, efficacy of NEO-PV-01 in combination with KEYTRUDA and chemotherapy

How the farm bill could erode part of the ACA

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in